DormoTech

DormoTech

paid

DormoTech's DormoVision X™ is an all-in-one wireless sleep diagnostics platform supporting HST, HSAT, and PSG with 38-channel data capture and automated AI analysis.

About

DormoTech is a Digital Health company specializing in the monitoring and diagnosis of sleep disorders through its flagship product, DormoVision X™. Designed for both home and in-lab environments, DormoVision X™ is a wireless, multi-channel sleep diagnostics system that enables clinicians to conduct high-quality sleep studies without the complexity and overhead of traditional lab setups. The platform captures 29 direct channels and 9 derived channels — including EEG, EOG, Chin EMG, SpO₂, Heart Rate, Nasal/Oral Airflow, Respiratory Effort, Snoring/Breathing Sounds, Body/Head Position, and modular ExG inputs — and delivers automated AI-driven analysis with a clinically validated 97% equivalence to in-lab PSG. It supports all sleep study types (Type 1, 2, and 3), making it a single unified solution for diverse diagnostic workflows. DormoVision X™ is pediatric-friendly (ages 6+), uses soft wireless materials with no nasal cannulas, and supports unlimited multi-night studies to capture night-to-night variability for more accurate diagnoses. Its cloud-based infrastructure centralizes data from unlimited locations on a flexible, usage-based model, allowing sleep practices to scale without adding beds, equipment, or staff. The platform covers the full diagnostic workflow — prescribing, monitoring, analysis, and reporting — in one streamlined system, reducing delays, minimizing retests, and improving patient outcomes.

Key Features

  • 38-Channel Physiological Data Capture: Records 29 direct and 9 derived channels including EEG, EOG, EMG, SpO₂, ECG, airflow, respiratory effort, snoring, and body position for comprehensive sleep analysis.
  • Supports All Sleep Study Types (1, 2 & 3): A single platform compatible with HST, HSAT, and full PSG workflows — eliminating the need for multiple diagnostic devices across different study types.
  • 97% Equivalence with In-Lab PSG: Clinically validated to deliver near-perfect agreement with gold-standard in-lab polysomnography, ensuring diagnostic confidence without sacrificing patient comfort.
  • Unlimited Multi-Night Studies: Captures night-to-night variability through unlimited multi-night recordings, enabling more accurate diagnoses and personalized treatment planning.
  • Cloud-Based Centralized Platform: Manages prescribing, monitoring, automated analysis, and reporting in one unified system across unlimited locations on a scalable, usage-based model.

Use Cases

  • Sleep clinics running home sleep apnea tests (HSAT) that want to reduce patient burden while maintaining diagnostic-grade data quality.
  • Hospital-based sleep labs looking to extend services into home settings without investing in additional hardware or staff.
  • Pediatric sleep specialists needing a comfortable, wireless diagnostic solution suitable for children aged 6 and above.
  • Multi-location sleep medicine practices seeking a scalable, cloud-based platform to centralize study management and reporting across all sites.
  • Pulmonologists and neurologists integrating sleep diagnostics into broader respiratory or neurological care pathways without adopting separate platforms.

Pros

  • Lab-Quality Results at Home: Delivers in-lab PSG equivalence in a portable, wireless form factor, enabling clinics to extend diagnostics beyond the lab without sacrificing data quality.
  • All-in-One Workflow Integration: Covers the full diagnostic cycle — from prescribing to reporting — in a single platform, reducing administrative burden and eliminating the need to juggle multiple tools.
  • Pediatric-Friendly Design: Wireless, soft-material hardware with no nasal cannulas makes the device comfortable and suitable for children aged 6 and above, broadening the patient population served.
  • Scalable Usage-Based Model: Cloud-based infrastructure supports unlimited locations with a flexible pricing model, making it easy for growing sleep practices to scale without large capital expenditures.

Cons

  • Medical/Enterprise Pricing: Designed for clinical use, the platform is likely priced for healthcare organizations rather than individual consumers, with costs not publicly disclosed.
  • Requires Clinical Setup: While designed to be easier than traditional labs, the system still requires trained healthcare professionals to prescribe, oversee, and interpret study results.
  • Hardware Dependency: The platform's full capabilities rely on the DormoVision X™ physical device, meaning clinics must procure and manage the hardware in addition to the software subscription.

Frequently Asked Questions

What types of sleep studies does DormoVision X™ support?

DormoVision X™ supports all sleep study types — Type 1 (full in-lab PSG), Type 2 (unattended portable PSG), and Type 3 (home sleep apnea testing / HSAT) — all within a single platform.

How accurate is DormoVision X™ compared to traditional in-lab PSG?

DormoVision X™ has been clinically validated to achieve 97% equivalence with in-lab polysomnography, making it a reliable alternative for both home and clinic-based diagnostics.

Can DormoVision X™ be used with pediatric patients?

Yes. The wireless, soft-material design with no nasal cannulas makes DormoVision X™ suitable and comfortable for pediatric patients aged 6 and above.

How does the platform handle multi-location deployments?

DormoVision X™ is cloud-based and supports unlimited locations under one centralized platform with a flexible, usage-based pricing model, making it easy to scale across multiple clinics.

What physiological parameters does DormoVision X™ measure?

The device captures 29 direct channels and 9 derived channels, including EEG, EOG, Chin EMG, ECG, SpO₂, Heart Rate, Nasal/Oral Airflow, Respiratory Effort, Snoring, Body/Head Position, and modular ExG for leg, limb, and chest.

Reviews

No reviews yet. Be the first to review this tool.

Alternatives

See all